These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 34251340)

  • 1. Pulmonary Fibrosis Caused by Severe COVID-19 Infection: Discharge May Not Be The End of Treatment.
    Rumende CM
    Acta Med Indones; 2021 Apr; 53(2):141-142. PubMed ID: 34251340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Management of Pulmonary Fibrosis in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2021 Apr; 53(2):233-241. PubMed ID: 34251354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-COVID pulmonary fibrosis: therapeutic efficacy using with mesenchymal stem cells - How the lung heals.
    Vishnupriya M; Naveenkumar M; Manjima K; Sooryasree NV; Saranya T; Ramya S; Harysh Winster S; Paulpandi M; Balachandar V; Arul N
    Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2748-2751. PubMed ID: 33829461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial.
    Lu ZH; Yang CL; Yang GG; Pan WX; Tian LG; Zheng JX; Lv S; Zhang SY; Zheng PY; Zhang SX
    Infect Dis Poverty; 2021 Mar; 10(1):31. PubMed ID: 33731163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discharge may not be the end of treatment: Pay attention to pulmonary fibrosis caused by severe COVID-19.
    Zhang C; Wu Z; Li JW; Tan K; Yang W; Zhao H; Wang GQ
    J Med Virol; 2021 Mar; 93(3):1378-1386. PubMed ID: 33107641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung Transplantation for Patients With COVID-19.
    King CS; Mannem H; Kukreja J; Aryal S; Tang D; Singer JP; Bharat A; Behr J; Nathan SD
    Chest; 2022 Jan; 161(1):169-178. PubMed ID: 34418410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSCs transplantation may be a potential therapeutic strategy for COVID-19 treatment.
    Wang XY
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4537-4538. PubMed ID: 32373992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [COVID-19: A Pneumological Point of View - Long-Term Sequelae of COVID-19 - Implications For Follow-up In Respiratory Medicine].
    Leo F; Wormanns D; Grohé C
    Dtsch Med Wochenschr; 2020 Jul; 145(15):1086-1092. PubMed ID: 32731284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
    Michalski JE; Kurche JS; Schwartz DA
    Transl Res; 2022 Mar; 241():13-24. PubMed ID: 34547499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].
    Wang J; Wang BJ; Yang JC; Wang MY; Chen C; Luo GX; He WF
    Zhonghua Shao Shang Za Zhi; 2020 Aug; 36(8):691-697. PubMed ID: 32174095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary fibrosis secondary to COVID-19: a call to arms?
    Spagnolo P; Balestro E; Aliberti S; Cocconcelli E; Biondini D; Casa GD; Sverzellati N; Maher TM
    Lancet Respir Med; 2020 Aug; 8(8):750-752. PubMed ID: 32422177
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent Findings on Cell-Based Therapies for COVID19-Related Pulmonary Fibrosis.
    Chuang HM; Ho LI; Harn HJ; Liu CA
    Cell Transplant; 2021; 30():963689721996217. PubMed ID: 33845643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive Pulmonary Fibrosis After Non-Critical COVID-19: A Case Report.
    Doane JJ; Hirsch KS; Baldwin JO; Wurfel MM; Pipavath SN; West TE
    Am J Case Rep; 2021 Dec; 22():e933458. PubMed ID: 34848676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China.
    Li Y; Wu J; Wang S; Li X; Zhou J; Huang B; Luo D; Cao Q; Chen Y; Chen S; Ma L; Peng L; Pan H; Travis WD; Nie X
    Histopathology; 2021 Mar; 78(4):542-555. PubMed ID: 32926596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge.
    Wei J; Yang H; Lei P; Fan B; Qiu Y; Zeng B; Yu P; Lv J; Jian Y; Wan C
    J Xray Sci Technol; 2020; 28(3):383-389. PubMed ID: 32474479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Fibrosis Sequelae After Recovery from COVID-19 Infection.
    Susanto AD; Triyoga PA; Isbaniah F; Fairuz A; Cendikiawan H; Zaron F; Aryanti I; Irbah SN; Hidayat M
    J Infect Dev Ctries; 2021 Mar; 15(3):360-365. PubMed ID: 33839710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Postinflammatroy pulmonary fibrosis of COVID-19: the current status and perspective].
    Zhan X; Liu B; Tong ZH
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Sep; 43(9):728-732. PubMed ID: 32894907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations.
    Pehote G; Vij N
    Cells; 2020 Aug; 9(9):. PubMed ID: 32847034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cell Secretome for Post-COVID-19 Pulmonary Fibrosis: A New Therapy to Treat the Long-Term Lung Sequelae?
    Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Richeldi L; Corsico AG
    Cells; 2021 May; 10(5):. PubMed ID: 34068958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.